Skip to main content
Log in

Regulatory biocompatibility requirements for biomaterials used in regenerative medicine

  • Special Issue: ESB 2014
  • Biocompatibility Studies
  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

The biological safety of biomaterials used for implantable medical devices is usually determined by a series of standard tests that assess the effects that extractable substances have on cells in vitro and in simple short term animal studies. To use these tests to determine the suitability of materials for tissue engineering templates is inappropriate. This short essay discusses the issues that are involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. International Standards Organization, biological evaluation of medical devices, part 1 evaluation and testing, ISO 10993: 2003.

  2. Williams DF. The biomaterials conundrum in tissue engineering. Tissue Eng Part A. 2014;20(7–8):1129–31.

    Article  Google Scholar 

  3. Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol. 2006;24:4–8.

    Article  Google Scholar 

  4. Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29(20):2941–53.

    Article  Google Scholar 

  5. Williams DF. There is no such thing as a biocompatible material. Biomaterials. 2014;35:10009–14.

    Article  Google Scholar 

  6. Williams DF. Essential Biomaterials Science. Cambridge: Cambridge University Press; 2014. p. 670.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David F. Williams.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, D.F. Regulatory biocompatibility requirements for biomaterials used in regenerative medicine. J Mater Sci: Mater Med 26, 89 (2015). https://doi.org/10.1007/s10856-015-5421-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10856-015-5421-7

Keywords

Navigation